Similar articles

• [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].

  Janot C. Janot C. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):347-50. doi: 10.1016/s1140-4639(05)80042-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177596 French. No abstract available.
• [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U].

  Lunel F, Azar N, Fournel JJ, Valla D, Foucault C, Habibi B, Jaulmes D, Perrin M, Opolon P, Huraux JM. Lunel F, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):361-7. doi: 10.1016/s1140-4639(05)80046-2. Rev Fr Transfus Hemobiol. 1990. PMID: 2177600 French. No abstract available.
• [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].

  Couroucé AM. Couroucé AM. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):335-8. doi: 10.1016/s1140-4639(05)80039-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177594 Review. French. No abstract available.
• [Incidence of anti-HCV and ALT in blood donors].

  Martín Y, Marzo L, Cinto F, Delgado P, Buñuel C. Martín Y, et al. Sangre (Barc). 1990 Jun;35(3):197-200. Sangre (Barc). 1990. PMID: 2118686 Spanish.
• [Anti-HVC antibodies and raw-material plasma: reflections and strategy].

  Avenard G, Maquin A, Schoeffter C, Mangin C. Avenard G, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):351-4. doi: 10.1016/s1140-4639(05)80043-7. Rev Fr Transfus Hemobiol. 1990. PMID: 2177597 Review. French. No abstract available.